Principal Financial Group Inc Ocular Therapeutix, Inc Transaction History

Principal Financial Group Inc

$167 Billion
Q1 2025

A detailed history of Principal Financial Group Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 12,623 shares of OCUL stock, worth $101,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,623

Previous 13,420 5.94%

Holding current value

$101,110

Previous $114,000 19.3%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$5.93 - $9.08 $4,726 - $7,236	-797 Reduced 5.94%	12,623 $92,000
Q4 2024 Jan 31, 2025	BUY	$8.33 - $11.47 $111,788 - $153,927	13,420 New	13,420 $114,000
Q3 2024 Oct 31, 2024	SELL	$6.45 - $9.23 $76,129 - $108,941	-11,803 Reduced 44.77%	14,561 $126,000
Q2 2024 Jul 29, 2024	SELL	$4.2 - $8.69 $6,367 - $13,174	-1,516 Reduced 5.44%	26,364 $180,000
Q1 2024 Apr 29, 2024	BUY	$3.85 - $10.93 $22,795 - $64,716	5,921 Added 26.96%	27,880 $253,000
Q4 2023 Feb 07, 2024	SELL	$2.08 - $4.52 $232 - $506	-112 Reduced 0.51%	21,959 $97,000
Q3 2023 Nov 02, 2023	SELL	$3.14 - $5.04 $549 - $882	-175 Reduced 0.79%	22,071 $69,000
Q2 2023 Aug 07, 2023	SELL	$4.6 - $7.64 $2,875 - $4,775	-625 Reduced 2.73%	22,246 $114,000
Q1 2023 May 09, 2023	SELL	$2.79 - $6.27 $4,729 - $10,627	-1,695 Reduced 6.9%	22,871 $120,000
Q4 2022 Feb 09, 2023	BUY	$2.61 - $4.41 $11,669 - $19,717	4,471 Added 22.25%	24,566 $69,000
Q3 2022 Nov 09, 2022	SELL	$4.09 - $6.5 $1,946 - $3,094	-476 Reduced 2.31%	20,095 $84,000
Q2 2022 Aug 10, 2022	BUY	$3.01 - $5.22 $19,673 - $34,117	6,536 Added 46.57%	20,571 $83,000
Q1 2022 May 09, 2022	BUY	$4.83 - $7.35 $4,825 - $7,342	999 Added 7.66%	14,035 $69,000
Q4 2021 Feb 09, 2022	SELL	$6.16 - $12.07 $817,462 - $1.6 Million	-132,705 Reduced 91.06%	13,036 $91,000
Q3 2021 Nov 09, 2021	BUY	$9.7 - $14.34 $5,247 - $7,757	541 Added 0.37%	145,741 $1.46 Million
Q2 2021 Aug 10, 2021	BUY	$13.43 - $19.16 $1.55 Million - $2.22 Million	115,671 Added 391.72%	145,200 $2.06 Million
Q1 2021 May 10, 2021	SELL	$15.82 - $22.11 $13,225 - $18,483	-836 Reduced 2.75%	29,529 $484,000
Q4 2020 Feb 08, 2021	BUY	$7.91 - $22.95 $240,187 - $696,876	30,365 New	30,365 $628,000

Others Institutions Holding OCUL

# of Institutions

207

Shares Held

135M

Call Options Held

426K

Put Options Held

119K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $617M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Ocular Therapeutix, Inc Transaction History